Season 3, Episode 9 - JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
In this JHEP Live the faculty will be discussing the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections.
Faculty: Prof. Joerg Petersen (Moderator), Prof. Maria Buti (Faculty), Prof. Man-Fung Yuen (Faculty)
Articles of interest:
• Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
• N-acetyl galactosamine-conjugated antisense oligonucleotide (GSK3389404) in chronic hepatitis B patients on stable nucleos(t)ide therapy: Phase 2a, randomised, double-blind, controlled study
ℹ The episode will be broadcasted live on this page.